OPA1 Dominant Optic Atrophy: Pathogenesis and Therapeutic Targets

David C.S. Wong; Joshua P. Harvey; Neringa Jurkute; Sara M. Thomasy; Mariya Moosajee; Patrick Yu-Wai-Man; Michael J. Gilhooley

Journal ArticleOPEN ACCESS

OPA1 Dominant Optic Atrophy: Pathogenesis and Therapeutic Targets

Wong D
Harvey J
Jurkute N
et al.

Journal of Neuro-Ophthalmology (2023) 43(4) 464-474

DOI: 10.1097/WNO.0000000000001830

0Citations

6Readers

Get full text

Cite

CITATION STYLE

APA

Wong, D. C. S., Harvey, J. P., Jurkute, N., Thomasy, S. M., Moosajee, M., Yu-Wai-Man, P., & Gilhooley, M. J. (2023). OPA1 Dominant Optic Atrophy: Pathogenesis and Therapeutic Targets. Journal of Neuro-Ophthalmology, 43(4), 464–474. https://doi.org/10.1097/WNO.0000000000001830

OPA1 Dominant Optic Atrophy: Pathogenesis and Therapeutic Targets

Cite

Register to see more suggestions